Functionally Incomplete Re-Endothelialization of Stents and Neoatherosclerosis

Affiliations

¹ Centre for Inherited Cardiovascular Diseases, IRCCS Foundation University Hospital Policlinico San Matteo, Pavia, Italy. Electronic address: e.arbustini@smatteo.pv.it.
² Centre for Inherited Cardiovascular Diseases, IRCCS Foundation University Hospital Policlinico San Matteo, Pavia, Italy.
³ The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

Free article

Editorial

Eloisa Arbustini et al. JACC Cardiovasc Interv. 2017.

Free article

. 2017 Dec 11;10(23):2388-2391.

doi: 10.1016/j.jcin.2017.08.031. Epub 2017 Nov 1.

¹ Centre for Inherited Cardiovascular Diseases, IRCCS Foundation University Hospital Policlinico San Matteo, Pavia, Italy. Electronic address: e.arbustini@smatteo.pv.it.
² Centre for Inherited Cardiovascular Diseases, IRCCS Foundation University Hospital Policlinico San Matteo, Pavia, Italy.
³ The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York.

No abstract available

Keywords: biodegradable stent; cadherin; drug-eluting stent(s); endothelium; neoatherosclerosis; restenosis; stent thrombosis.

Comment on

Endothelial Barrier Protein Expression in Biodegradable Polymer Sirolimus-Eluting Versus Durable Polymer Everolimus-Eluting Metallic Stents.
Mori H, Cheng Q, Lutter C, Smith S, Guo L, Kutyna M, Torii S, Harari E, Acampado E, Joner M, Kolodgie FD, Virmani R, Finn AV. Mori H, et al. JACC Cardiovasc Interv. 2017 Dec 11;10(23):2375-2387. doi: 10.1016/j.jcin.2017.06.059. Epub 2017 Nov 1. JACC Cardiovasc Interv. 2017. PMID: 29102583